Genetic characterization of the wboA gene from the predominant biovars of Brucella isolates in Iran
Keywords:
Brucella , wboA gene , LPS , B. abortusAbstract
Introduction: Brucella spp. are gram-negative, facultative intracellular bacteria pathogens responsible for brucellosis, a zoonotic disease that can cause abortion, fetal death, and genital infections in animals and undulant fever in humans. Lipopolysaccharide (LPS) is known as a major virulence factor of Brucella spp. The wboA gene is capable of encoding a glycosyltransferase that appears to play a major role in LPS biosynthesis. Hence, the characterization of this gene can help in the clarification of the pathogenicity of Brucella spp.
Methods: This study was carried out at Razi Vaccine and Serum Research Institute in 2011. Briefly, the wboA gene in B. abortus biovar 3 and B. melitensis biovar 1, the predominant biovars in Iran, were amplified by using two pairs of specific primers. Polymerase chain reaction (PCR) products were cloned into a thymine–adenine (TA) cloning vector and transformed into an E. coli DH5α before being sequenced. Multiple alignments of identified sequences were performed, with all wboA sequences deposited in the GenBank sequence database.
Results: This study showed that a mismatch has occurred in B. melitensis biovar 1; this biovar is predominant in Iran. In contrast, the wboA gene from B. abortus biovar 3 was similar to that of other B. abortus variations.
Conclusion: The comparison and alignment of the wboA gene of native Brucella strains in Iran to all wboA sequences deposited in GenBank revealed that the wboA gene has changed in the long term; hence, because of its unique nucleotide pattern, the gene can be used for specific diagnosis of B. abortus and B. canis.
References
Probert WS, Schrader KN, Khuong NY, Bystrom SL, Graves MH. Real-time multiplex PCR assay for
detection of Brucella spp., B. abortus, and B. melitensis. J Clin Microbiol. 2004; 42(3):1290-1293. doi:
1128/JCM.42.3.1290-1293/2004. PMID: 15004098, PMCID: PMC35686.
Corbel MJ: Brucellosis: an overview. Emerg Infect Dis. 1997; 3(2): 213–221. doi:
3201/eid0302.970219. PMID: 9204307, PMCID: PMC2627605.
Cutler S, Whatmore A, Commander N. Brucellosis–new aspects of an old disease. J Appl Microbiol. 2005;
(6):1270-81. Doi: 10.1111/j.1365-2672.2005.02622.x. PMID: 15916641.
Foster G, Osterman BS, Godfroid J, Jacques I, Cloeckaert A. Brucella ceti sp. nov. and Brucella
pinnipedialis sp. nov. for Brucella strains with cetaceans and seals as their preferred hosts. Int J Syst Evol
Microbiol. 2007; 57(11):2688-93. Doi: 10.1111/j.1365-2672.2005.02622.x. PMID: 1797824.
Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2010;
(3-4):392-8. doi: 10.1016/j.vetmic.2009. PMID: 19604656.
Schurig GG, Sriranganathan N, Corbel MJ: Brucellosis vaccines: past, present and future. Vet Microbiol.
; 90(1-4):479-96. PMID: 12414166.
Taleski V et al. An overview of the epidemiology and epizootology of brucellosis in selected countries of
Central and Southeast Europe. Vet Microbiol. 2002; 90(1-4):147-55. Doi: 10.1016/S0378-1135(02)00250- X. PMID: 12414140.
Pappas G, Bosilkovski M, Akritidis N, Mastora M, Krteva L, Tsianos E: Brucellosis and the respiratory
system. Clin Infect Dis. 2003; 37(7):95-9. Doi: 10.1086/378125. PMID: 13130417
Chen Y et al: Changes of predominant species, biovars and sequence types of Brucella isolates. Infect Dis.
; 13(514).2-9. doi: 10.1186/1471-2334-13-514. PMID: 24176041. PMCID: PMC3819263
Zowghi E, Ebadi A. Yarahmadi M: Isolation and identification of Brucella organisms in Iran. Archives of
Clinical Infectious Diseases 2009; 3(4):185-188.
De Tejada GM, Pizarro-Cerda J, Moreno E, Moriyon I. The outer membranes of Brucella spp. are resistant
to bactericidal cationic peptides. Infect Immun. 1995; 63(8):3054-61 PMID: 7622230. PMCID:
PMC173416.
Moreno E, Berman D, Boettcher L. Biological activities of Brucella abortus lipopolysaccharides. Infect
Immun.1981; 31(1):362-370. PMid: 6783538 PMCid: PMC351792.
Moreno E, Jones L, Berman D. Immunochemical characterization of rough Brucella lipopolysaccharides.
Infect Immun. 1984; 43(3):779-782. PMID: 6421737. PMCID: PMC264247.
Godfroid F et al. Identification of the Perosamine Synthetase Gene of Brucella melitensis 16M and
Involvement of Lipopolysaccharide O Side Chain in BrucellaSurvival in Mice and in Macrophages. Infect
Immun. 1998; 66(11):5485-5493. PMID: 9784561. PMCID: PMC108687.
Schnaitman CA1, Klena JD. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol
Rev. 1993;57(3):655-82. PMID: 7504166. PMCID: PMC372930.
Zygmunt MS, Blasco JM, Letesson J-J, Cloeckaert A, Moriyón I. DNA polymorphism analysis of Brucella
lipopolysaccharide genes reveals marked differences in O-polysaccharide biosynthetic genes between
smooth and rough Brucella species and novel species-specific markers. BMC Microbiol. 2009;9(92). doi:
1186/1471-2180-9-92. PMID: 19439075. PMCID: PMC2698832
Wang Z, Niu J, Wang S, Lv Y, Wu Q. In vivo differences in the virulence, pathogenicity, and induced
protective immunity of wboA mutants from genetically different parent Brucella spp. Clin Vaccine
Immunol. 2013; 20(2):174-180. doi: 10.1128/CVI.00573-12. Epub 2012 Dec 12. PMID: 23239800.
PMCID: PMC3571281.
Vemulapalli R, He Y, Buccolo LS, Boyle SM, Sriranganathan N, Schurig GG. Complementation of
Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine
efficacy but no change in rough phenotype and attenuation. Infect Immun. 2000; 68(7):3927-3932. Doi:
1128/IAI.68.7.3927-3932.2000. PMID: 10858205 PMCID: PMC101669.
Vemulapalli R, McQuiston JR, Schurig GG, Sriranganathan N, Halling SM, Boyle SM. Identification of an
IS711 Element Interrupting the wboA Gene of Brucella abortus Vaccine Strain RB51 and a PCR Assay To
Distinguish Strain RB51 from Other Brucella Species and Strains. Clin Diagn Lab Immunol. 1999;
(5):760-764. PMID: 10473532 PMCID: PMC95769.
Muyrers JP, Zhang Y, Stewart AF. Techniques: Recombinogenic engineering--new options for cloning and
manipulating DNA.Trends Biochem Sci. 2001;26(5):325-31. Doi: 10.1016/S0968-0004(00)01757-6.
PMID: 11343926.
Godfroid J et al. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century.
Prev Vet Med. 2011;102(2):118-31. doi: 10.1016/j.prevetmed.2011.04.007. Epub 2011 May 14. PMID:
Verger J-M, Grimont F, Grimont PA, Grayon M. Brucella, a monospecific genus as shown by
deoxyribonucleic acid hybridization. International Journal of Systematic Bacteriology 1985; 35(3):292-295.
Doi: 10.1099/00207713-35-3-292.
Halling SM et al. Completion of the genome sequence of Brucella abortus and comparison to the highly
similar genomes of Brucella melitensis and Brucella suis. J Bacteriol . 2005; 187(8):2715-2726. Doi:
1128/JB.187.8.2715-2726.2005. PMID: 15805518. PMCID: PMC1070361.
Vergnaud. SHCG. Molecular characterization of Brucella species. Rev Sci Tech. 2013; 32(1):149-162.
PMid: 23837373
Banai M, Mayer I, Cohen A. Isolation, identification, and characterization in Israel of Brucella melitensis
biovar 1 atypical strains susceptible to dyes and penicillin, indicating the evolution of a new variant. J Clin
Microbiol.1990; 28(5):1057-1059. PMID: 2191005. PMCID: PMC267865
Published
Issue
Section
License
Copyright (c) 2020 knowledge kingdom publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
